Estimated Cost Savings of Increased Use of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Canada-Reference-Cited by-同舟云学术

Estimated Cost Savings of Increased Use of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Canada

Published:2007-06 Issue:6 Volume:38 Page:1952-1955
ISSN:0039-2499
Container-title:Stroke
language:en
Short-container-title:Stroke

Author:

Yip Todd R.¹,Demaerschalk Bart M.¹

Affiliation:

1. From Department of Physical Medicine and Rehabilitation (T.R.Y.), University of Saskatchewan, Saskatoon, SK, Canada; Department of Neurology (B.M.D.), Mayo Clinic, Scottsdale, Ariz.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)

Reference26 articles.

1. Heart and Stroke Foundation. c2006 [cited 2006 May 24]. Available at: http://ww2.heartandstroke.ca/Page.asp?PageID=33&ArticleID=428&Src=stroke&From+SubCategory.

2. Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study

3. Campbell C. A stroke strategy for Canada. Canadian Stroke Network. [cited 2005 July 9]. Available at: http://canadianstrokenetwork.ca/news/newsletters/newsletter8en.pdf.

4. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravenous Grafts of Human Amniotic Fluid-Derived Stem Cells Reduce Behavioral Deficits in Experimental Ischemic Stroke;Cell Transplantation;2019-06-04

2. Neuroprotective effect ofPanax ginsengextract against cerebral ischemia–reperfusion-injury-induced oxidative stress in middle cerebral artery occlusion models;FACETS;2019-06-01

3. Endothelial Progenitor Cells Modulate Inflammation-Associated Stroke Vasculome;Stem Cell Reviews and Reports;2019-02-09

4. Mobile Stroke Units - Cost-Effective or Just an Expensive Hype?;Current Atherosclerosis Reports;2018-08-29

5. Combination therapy for ischemic stroke: Novel approaches to lengthen therapeutic window of tissue plasminogen activator;Brain Circulation;2018